HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development

NodeGuardian · 2026-03-10T17:52:51+00:00

HeartBeam partners with the Icahn School of Medicine at Mount Sinai to enhance AI-ECG algorithms using clinical data and AI expertise, aiming to improve cardiac monitoring and broaden applications in preventive cardiology and chronic disease management.

NodeGuardian

2026-03-10 17:52:51

Abstract generation in progress

HeartBeam (NASDAQ: BEAT) has announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai to accelerate the development and validation of next-generation AI-ECG algorithms. This partnership aims to combine HeartBeam’s patented ECG platform with Mount Sinai’s clinical data and AI expertise to advance AI-driven cardiac monitoring and support personalized cardiac insights. The initiative seeks to expand clinical indications and enable broader applications in preventive cardiology, chronic disease management, and remote patient monitoring.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.